Summary of findings ‐ nebulisers for delivering tobramycin: conventional systems vs VMT and AAD
Quality of life · children aged 6 ‐ 18 with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found